Radiomic features based on pyradiomics predict CD276 expression associated with breast cancer prognosis

Background: CD276 is a promising immune checkpoint molecule with significant therapeutic potential. Several clinical trials are currently investigating CD276-targeted therapies. Purpose: This study aims to assess the prognostic significance of CD276 expression levels and to predict its expression us...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Yong Li, Chun-mei Chen, Wei-wen Li, Ming-tao Shao, Yan Dong, Qun-chen Zhang
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	CD276 Magnetic resonance imaging Radiomics Prognosis Breast cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024133762